The horror has finally happened. The $1,500-a-month metabolic flex is dead. Patents for weight-loss drugs have expired in India and China. Now, generic jabs are flooding the market for a measly $15.

Mayfair and the Upper East Side are in a total tailspin. Their favorite status symbol is being handed out to the middle class like candy. If everyone is thin, then being thin doesn't mean anything anymore.

Novo Nordisk is doing its best to save the velvet rope. They just secured FDA approval for a 'premium' high-dose version. It’s the same drug, but more expensive and harder to get. It’s the ultimate defensive maneuver for the elite. Because in this town, a medical miracle is only worth having if your neighbor can't afford it.